- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01202578
Evaluation of the Tympanostomy Tube Delivery System (inVENT-OR)
June 10, 2014 updated by: Acclarent
A Clinical Study of the Acclarent Tympanostomy Tube Delivery System for the Treatment of Patients Requiring Tympanostomy Tube Insertion for Otitis Media
The purpose of this study is to evaluate the performance and safety of the Tympanostomy Tube Delivery System (TTDS) for chronic otitis media or recurrent acute otitis media.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
53
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Florida
-
Port St. Lucie, Florida, United States, 34952
- South Coast ENT
-
-
Kentucky
-
Louisville, Kentucky, United States, 40207
- Advanced ENT and Allergy
-
-
Texas
-
San Antonio, Texas, United States, 78240
- Ear Medical Group
-
-
Washington
-
Kirkland, Washington, United States, 98034
- Evergreen Sinus Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 months and older (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Diagnosed with either chronic otitis media with effusion or acute otitis media and scheduled to undergo tympanostomy tube insertion
Exclusion Criteria:
- Reaction to anesthesia
- Markedly atrophic, bimeric, severely retracted, atelectatic or perforated tympanic membrane
- Otitis externa
- Active acute otitis media
- Otitis media pathology requiring T-tubes
- Stenosed ear canal
- Anatomy that precludes visualization and access to tympanic membrane
- Anatomy that necessitates tympanostomy tube placement in posterior half of membrane
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: tympanostomy tube
performance and safety of tympanostomy tube delivery system
|
tympanostomy tube delivery system
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Safety of Tympanostomy Tube (TT) Delivery System
Time Frame: 7 days
|
Occurrence of pre-defined Safety Events of acoustic trauma, deployment of the TT into the middle ear, damage to middle ear structures, unintended tympanic membrane perforation requiring treatment, abrasion to the external acoustic meatus requiring significant treatment, and major bleeding requiring significant treatment.
|
7 days
|
Device Success
Time Frame: 0 days
|
Device Success is defined as the successful delivery of the tympanostomy tube across the tympanic membrane using the tympanostomy tube delivery system (TTDS).Device Success is evaluated on a per device basis.
|
0 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Proportion of Subjects With Procedure Success
Time Frame: 0 days
|
Procedure Success was defined as the successful placement of any tympanostomy tube in all enrolled ears in a given subject.
Non-Acclarent tubes successfully placed manually following non-success of the TTDS were counted toward Procedure Success.
Procedure Success was determined on a per subject basis: the rate was calculated by the number of subjects achieving Procedure Success out of the total number of enrolled subjects.
|
0 days
|
Tube Retention
Time Frame: 7 days
|
Presence of the tympanostomy tube across the tympanic membrane at the follow-up visit.
|
7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kenneth Faw, MD, Evergreen Sinus Center
- Principal Investigator: Andrew Gould, MD, Advanced ENT and Allergy
- Principal Investigator: Jacob Zeiders, MD, South Coast ENT
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2010
Primary Completion (ACTUAL)
November 1, 2010
Study Completion (ACTUAL)
December 1, 2010
Study Registration Dates
First Submitted
September 13, 2010
First Submitted That Met QC Criteria
September 14, 2010
First Posted (ESTIMATE)
September 16, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
July 11, 2014
Last Update Submitted That Met QC Criteria
June 10, 2014
Last Verified
June 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CPR005013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Otitis Media With Effusion
-
Bezmialem Vakif UniversityCompleted
-
Nationwide Children's HospitalWithdrawn
-
Alcon ResearchCompletedOtitis Media With Effusion in Children | Otitis Media Recurrent
-
Tusker MedicalCompletedAOM - Acute Otitis Media | OME - Otitis Media With EffusionUnited States, Canada
-
David Chi, MDRecruitingRecurrent Acute Otitis Media | Chronic Otitis Media With Effusion | Otitis Media in ChildrenUnited States
-
Boston Medical CenterWithdrawnOtitis Media With Effusion in Children | OtorrheaUnited States
-
Eye & ENT Hospital of Fudan UniversityChildren's Hospital of Fudan University; Xinhua Hospital, Shanghai Jiao Tong...Not yet recruitingOtitis Media With Effusion in Children
-
Alcon ResearchCompletedOtitis Media With Effusion in Children | Otitis Media Recurrent
-
University Hospital, GhentWithdrawn
-
Yuinvent Innovations Ltd.UnknownOtitis Media With Effusion
Clinical Trials on tympanostomy tube
-
Zealand University HospitalDanish Medical AssociationCompletedQuality of Life | Sleep | Otitis Media With Effusion in ChildrenDenmark
-
Eye & ENT Hospital of Fudan UniversityChildren's Hospital of Fudan University; Xinhua Hospital, Shanghai Jiao Tong...Not yet recruitingOtitis Media With Effusion in Children
-
AcclarentCompletedOtitis Media With EffusionUnited States
-
Preceptis Medical, Inc.Completed
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingOtitis Media With Effusion After Nasopharyngeal CarcinomaChina
-
AcclarentCompleted
-
Alcon ResearchCompletedOtitis Media With Effusion in Children | Otitis Media RecurrentUnited States
-
Alcon ResearchCompletedOtitis Media With Effusion in Children | Otitis Media Recurrent
-
Bezmialem Vakif UniversityCompleted